var data={"title":"Society guideline links: Opioid use disorder and withdrawal","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Society guideline links: Opioid use disorder and withdrawal</div><p class=\"disclosureLink\"></p><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p><strong>Introduction</strong> &mdash; This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.</p><p>The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.</p><p>Links related to guidelines are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-alcohol-use-disorders-and-withdrawal\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Alcohol use disorders and withdrawal&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-cannabis-use-disorder-and-withdrawal\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Cannabis use disorder and withdrawal&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-benzodiazepine-use-disorder-and-withdrawal\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Benzodiazepine use disorder and withdrawal&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-stimulant-use-disorder-and-withdrawal\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Stimulant use disorder and withdrawal&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2106922554\"><span class=\"h1\">International</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.acepnow.com/world-health-organization-recommendations-for-community-management-of-opioid-overdose/?singlepage=1&theme=print-friendly&amp;token=7C6Py4svlnu8PE/P81nEWg/J8fYwSRx0KcqJzx4Eg2p51A9ALq9cArQE6MHJNQNyLw2PkEl3QNvbwo4Q+F0nKUF1YEfNBa93NjuAa8OvnorI2AeBcuCtAGkuR6qfvOFtFkXUsU6ZKOGhdRiiG5ET0UsRd+clW5F22nAx155jWwE=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">World Health Organization (WHO): Recommendations for community management of opioid overdose reviewed by American College of Emergency Physicians (ACEP) Clinical Policies Committee</a> (2016) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://apps.who.int/iris/bitstream/10665/137462/1/9789241548816_eng.pdf?ua=1&ua=1&amp;token=iUjpwLhlinb7Eb8A4cNDdwYyt5BIaZTVs3RgjQVpeXDeA2D1TmjD+bGT+2c2fxBG1UyjVRIhZIyHGdBEmjivYkQmVTeO8lWn+vHsU6faN4LJvwfhClBtdyVR9tluM3PM&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">WHO: Community management of opioid overdose</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Guidelines_Addiction_Part_2.pdf&amp;token=50Tmb3/8Llb9/c6z3JGwZG8qN/VtAzr1pIuLGYIilA1yQ/OJSBljZ6m90ebuPFd6KtYxoLgH3KLQq5cF4vSprcM7LycXbNPij8/3EB4Dijl8p7AniEFTZ7V7s0jYpC65&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">The World Federation of Societies of Biological Psychiatry (WFSBP): Guidelines for the biological treatment of substance use and related disorders, part 2 &minus; Opioid dependence</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.wpro.who.int/publications/docs/ClinicalGuidelines_forweb.pdf&amp;token=wWKRLdp5c8TglhddSNxU0eTTsW5O8h8DBWCfiqTuQBgdJwiLa+cLDY1u5i5H47cc8HzG/cb7kCngKGNRJbTx5Od/xabAlrYo4Y15nZ+ANhc=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">WHO: Clinical guidelines for withdrawal management and treatment of drug dependence in closed settings</a> (2009)</p><p/><p><strong>Canada</strong> </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.aacp.com/article/buy_now/?id=173&amp;token=Zhk3SsDNzGEOSDTcBVv9fcho7RSuzqFQh6EmuwnKeszSXnqwFi6jhlKNMrqAiItVDC/+Kq3fAfLiNpQR0ZN4Sg==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force: Recommendations for the management of patients with mood disorders and comorbid substance use disorders</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.cfp.ca/content/cfp/57/11/1257.full.pdf&amp;token=8Mkz6VncfvDn3viBfLyfgiPZN063UEVT15JrUl4Q9KI+cIUs2lQeCpsvSoRJU/kuXkowN5KqXdN9KYzVCVL+gQ==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">Canadian guideline for safe and effective use of opioids for chronic noncancer pain: Clinical summary for family physicians &minus; Part 1: General population</a> (2011)</p><p/><p class=\"headingAnchor\" id=\"H1073481588\"><span class=\"h1\">United States</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://annals.org/aim/article/2613555/health-public-policy-facilitate-effective-prevention-treatment-substance-use-disorders&amp;token=a4O62W+TYTdmIEIEbiDFLDV+Z4ItkGxsxLt5XZs9g0v6jL21tYAMTCr5eNAoGHy2W6c/aP1i2RazCnP7EK8YPWs4XM6YhW8vY4DtM8QJbZm31BSNwRn6dYlvlLEhxSx6TAWuu+yRWEGLrSKqmSJcRg==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">American College of Physicians (ACEP): Position paper on health and public policy to facilitate effective prevention and treatment of substance use disorders involving illicit and prescription drugs</a> (2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.painphysicianjournal.com/current/pdf?article=NDIwMg%3D%3D&journal=103&amp;token=oLXb6NSMOZdF35h7AB6nuTK9qVUwFvNKhs1OxuRy/ueyNL2JDAEF2REvM19OvYoqhdnxZmjLiPYDbC9nDWGP2pYsu946Yx9mEuuEH5ylCqQHWOD9PD2PACQZPB1UE9c/&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">American Society of Interventional Pain Physicians (ASIPP): Guidelines for responsible, safe, and effective prescription of opioids for chronic non-cancer pain</a> (2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.healthquality.va.gov/guidelines/Pain/cot/VADoDOTCPG022717.pdf&amp;token=sL+p+gWoM5K8OZ3TcR7z2WAY32Ka/u1lbC6jdvtVYpmiPQ4CtzqrxblFJ3evgisSbqW7L6915NuwQEgQnHnPIfF5ZlHrXTuxTgxIJiDbbVPITJxLYVPA+0SnJp/RN8+n&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">US Department of Veterans Affairs/Department of Defense (VA/DoD): Clinical practice guideline for opioid therapy for chronic pain</a> (2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://pediatrics.aappublications.org/content/pediatrics/138/3/e20161893.full.pdf&amp;token=WT3F/8JRn4ZIQKhu8VBNQN4WiGe3Jw0Ro5Jq8d4fHIkfdQcLB89oixB39sVhUqZ74pv4oYGklW+XBhbDWdQyR2Fzw1vWoHGdgh0OieRD9eQ=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">American Academy of Pediatricians (AAP): Medication-assisted treatment of adolescents with opioid use disorders</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781802/pdf/13181_2015_Article_529.pdf&amp;token=wEsKVFvqlKzpT+qOtddW/9WyS2+mbISD1cPa9SCgRnci8vyKZ2/mnf2fB28fHUVWJ32ACj3zWGXl2KVVa3TdeKnVZI7RF57F6Mnc/05z4D5fvSVMIbbOPwnTKM8YYHEl&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">American College of Medical Toxicology (ACMT): Position statement on safety issues regarding prescription opioids</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.cdc.gov/media/modules/dpk/2016/dpk-pod/rr6501e1er-ebook.pdf&amp;token=kkKj9FOgi7Ph9JRsDEoF40zFLLAlOtlHH9ZgKA3wz6rVAShFcfsGJ8yds3clajiQAedclLqt7V7hXZhN7QpTX+uI/rErdLpqErSYCH2FDEs=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">Centers for Disease Control and Prevention (CDC): Guideline for prescribing opioids for chronic pain &minus; United States</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-jam-article.pdf&amp;token=7qhbP0ys0y6sQGjlpsCf6VrUdbCNNZ8isloR1Pf8P5wLRTdWm6q8/RZG++kGYvElAE7k9zkCzrD/e4fNtc1pkul4mU96cq4Q3mv9zfThR1NqKbg82aR1Hm7Vo0E+BCIvXPord1OnX1Dox7jG1w0s7Q==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">American Society of Addiction Medicine (ASAM): National practice guideline for the use of medications in the treatment of addiction involving opioid use</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/aua-post-operative-opioid-analgesia/&amp;token=17sm/VgRB9+kPuASC1YJpTt1d5XoYG+IC6/e5E+sVEGccHc807t1cXKKGMvVb3jumHez1UxlfiXV7/VPfWYHEYKeo5FIZ5Zl/XhD4RaFxYI=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">Choosing Wisely: Don&rsquo;t continue opioid analgesia beyond the immediate postoperative period; prescribe the lowest effective dose and number of doses required to address the expected pain</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPGRevised22216.pdf&amp;token=sL+p+gWoM5K8OZ3TcR7z2WAY32Ka/u1lbC6jdvtVYplDI0rs/DHw81TdGI6zVlnNCLP+1pMC10A52nend3MprFknSAx+rhIRQPiX12p6yhTzdn4R1+LqwKt+My4GrnOr&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">VA/DoD: Clinical practice guideline for the management of substance use disorders</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/american-society-anesthesiologists-opioid-analgesics-as-long-term-therapy-for-non-cancer-pain/&amp;token=BKCYOc2VvIVEZ3iEnlln1uf/27DUFZlsFxhc/rKYraozOrKUR3SQlgxyomYvIG5WIQPVm9dt7EsAE6vKhVno2aRCNqwhCnVGUzgOvWEFy89mwfNNsipx7kWdhOfqH8vYYZ/qn4OlEAKS0qfxiyMNgA==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">Choosing Wisely: Don&rsquo;t prescribe opioid analgesics as long-term therapy to treat chronic non-cancer pain until the risks are considered and discussed with the patient</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/american-college-occupational-environmental-medicine-opioids-for-workers-at-safety-sensitive-jobs/&amp;token=xFvyDgoMAXMiLn/+I7GQC8aOoRn7Fv33S8iomsOTW9803Gia0wvBahyPslB2uUbgbE8xV5iEneVvAPfURzSm1gKJbAezxFOmORuiv1VDbBmHlq/FUvSvJud4LPFnB1imPiP89RQn5KeTEcOrbZeBwPG6Z+CoLjaW2fFAewUB7Pw=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">Choosing Wisely: Don&rsquo;t prescribe opioids for treatment of chronic or acute pain for workers who perform safety-sensitive jobs such as operating motor vehicles, forklifts, cranes or other heavy equipment</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951636/pdf/13181_2013_Article_323.pdf&amp;token=wEsKVFvqlKzpT+qOtddW/9WyS2+mbISD1cPa9SCgRnci8vyKZ2/mnf2fB28fHUVWkwFK+9DAhU6pBqeI/vluDqXBVMd90wvmTUO15sAx4aFZhaTrxx54lj4N/DXQTl9U&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">National Association of Medical Examiners (NAME): Complete republication of recommendations for the for the investigation, diagnosis, and certification of deaths related to opioid drugs</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/substanceuse-watch.pdf&amp;token=Gqp4B20mCnqM0Au3I5S6e4ySd78beD0XF5YnI+oJS15wdZS/y/hD3WjJGzAD8WnA7cNKrN5B1dLzX0JVmsocVtUJlunzcBoOI1rhfTlGiTJcL5a/e2isiuMux179Li6F&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">American Psychiatric Association (APA): Guideline watch &minus; Practice guideline for the treatment of patients with substance abuse disorders, 2nd edition</a> (2007)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><a href=\"http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/substanceuse.pdf&amp;token=FbcQzE9bBRIlfE+LIVNMKlgcvu6vo+MBYOxDi3oL5UDh3e+3z7lNsRyOWCjaGoqgznxBcI8uyc0QW6k9DqaQWu6Awo4SbNqb06JsvwVY/EyIE8arj9GtsmW2ILUDjxam&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">APA: Practice guideline for the treatment of patients with substance use disorders, 2nd edition</a> (2006)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK64115/pdf/Bookshelf_NBK64115.pdf&amp;token=wEsKVFvqlKzpT+qOtddW/y3+Lj0shalBW+L1ZyL4trzQNKrXNRfnbDB+moin6vffKWIqcE32vsILtI122PbBvZMEBHF7eogxToXG722IQ+8=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">SAMHSA: Detoxification and substance abuse treatment &minus; A Treatment Improvement Protocol (TIP)</a> (2006)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK64197/pdf/Bookshelf_NBK64197.pdf&amp;token=wEsKVFvqlKzpT+qOtddW/y3+Lj0shalBW+L1ZyL4trxbDALImH1NH6oNWBeAdDZEKWIqcE32vsILtI122PbBvXo2keP3V4XfqfEwDbHnWJE=&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">SAMHSA: Substance abuse treatment for persons with co-occurring disorders &minus; A Treatment Improvement Protocol (TIP)</a> (2005) </p><p/><p class=\"headingAnchor\" id=\"H3291839487\"><span class=\"h1\">United Kingdom</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/ng64/resources/drug-misuse-prevention-targeted-interventions-pdf-1837573761733&amp;token=kMe9uRQl8n6Yqa7SsPcKXWugr9OZKWl0+Zy9LGGwH37BPMTNG8LXlIdTZyqu+iN8OX2CphJBbsKoWmUjucsq/5vnWVzcq3Jrv35AdAGP0iLDu20omtJPkbov9dKupG+46ZRkZEZZxHsx1XABuOq6ng==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">National Institute for Health and Care Excellence (NICE): Guideline for drug misuse prevention &minus; Targeted interventions</a> (2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/ng46/resources/controlled-drugs-safe-use-and-management-pdf-1837456188613&amp;token=+mpNJocdpZnrt+jGUOCISiDGNXCV96tXvU0prNynxE/q14rkztOiaqq/FhFcVQCpol3EPwBITtKfCfVpj34nEr2C5mF4qR7AkQQjUIx0j0MMZllXoSDjE5X67pNr4RMkrwC1JCwUsNIWoeWxLU0oqw==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">NICE: Guideline on controlled drugs &minus; Safe use and management</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/qs23/resources/drug-use-disorders-in-adults-pdf-2098544097733&amp;token=uDPjmwDb8i/Vlgj5lAYoO0KVHv49ff74CDWiLASaVcIc3V+XFJNJc/d6BSHK09LQNNkkNsChy6F/U6PkBkOF6TeLqnGmf95ZDiRymWz55G/SmJCsKN4+MG0pKWOeQmWh&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">NICE: Quality standard on drug use disorders in adults</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg120/resources/coexisting-severe-mental-illness-psychosis-and-substance-misuse-assessment-and-management-in-healthcare-settings-pdf-35109443184325&amp;token=aHS0ygdHuR325ZXEG9ZQZwxyXlsO7kg7mGKzikrJzS/O3zn6z7HC2glXzXnw3x0eqKVkqXV1efX8ww/TZrSaiFfdBIjQRootpee5J8TgdF0s1FblxHmj6thDu1CsWypxLIkaUpk7tnadnNp45nzsijbn5uk206WZ5lA6btdkE4UI1gAdVQV3EhwQzO4v6epo&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">NICE: Clinical guideline on coexisting severe mental illness (psychosis) and substance misuse &minus; Assessment and management in healthcare settings</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg52/resources/drug-misuse-in-over-16s-opioid-detoxification-pdf-975504131269&amp;token=je4LWDmaw8hVCt2M3VjYXabr5+TL+jl4NnOHU3yUAisDOm0q6rJ+zxViR2yiDwBHN5peIjhVayOj2vyxZh4Hp7PlqPZRvV4TcU9qUujP8UuufeOu227YYhdKx4z8qYbfUj/wkHmW9/JFQJYz8A76xQ==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">NICE: Clinical guideline on drug misuse in over 16s &minus; Opioid detoxification</a> (2007)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.nice.org.uk/guidance/cg51/resources/drug-misuse-in-over-16s-psychosocial-interventions-pdf-975502451653&amp;token=8xbYM37JZ8sy+tPQo4gcyfDVwJi/BxmWOiNU1U0d5AMfA7tE4WBwnLb5yhYnSoNeaSo4IRIc7vKn8JRy3OvXDJsTyNrW2cr+mUdqgx1VaIYQ1HuMlqwpAQeVMWiD4077cY3veHFXwbO1+24Uupx4mQ==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">NICE: Clinical guideline on drug disuse in over 16s &minus; Psychosocial interventions</a> (2007)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/ta115/resources/naltrexone-for-the-management-of-opioid-dependence-pdf-82598074558405&amp;token=/TaeFX7eACl4jGTE9dmFLSXda4QjH988UidruSayDHsunndMfqQ4iytTqbmY5stceuAfrcecUuII83tGhYHWX/q/tQ5ga465SVk2Y5mrmNXdFQirkakAQvcJmaJ+U4MqewCe4HZOPbQmn43+tzWyGg==&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">NICE: Technology appraisal guidance for naltrexone for the management of opioid dependence</a> (2007)</p><p/><p class=\"headingAnchor\" id=\"H1927914767\"><span class=\"h1\">Australia</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/Publishing.nsf/content/AD14DA97D8EE00E8CA257CD1001E0E5D/$File/National_Guidelines_2014.pdf&amp;token=HNHAc9PFw5rB2SV3V8rKDSJ6FI6kJ0eZ6ZAxMW7bQYJI+n7nW95rOO7uwkTL/7/h9uwmVVoAzbioYQDOKMAC7MpCxoZvzRBwpD2AMm2L/SJIezrcnj8ANBqHS7FCs1YyBivILWFiIKr/fsPcm/SQeNnXF7zFkBOuhlx9tPMw0bAybaDim2Imtp8Gw/s8IHBw&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">Australian National Health and Medical Research Council (NHMRC): National guidelines for medication-assisted treatment of opioid dependence</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.clinicalguidelines.gov.au/portal/2492/alcohol-and-other-drug-withdrawal-practice-guidelines&amp;token=GxPhp9fsxndc/7KtdKu0a1/6oBrR1bGgVbW3kXDFWuvs5oO6bnM9xSVpiO50Lqe3jtlaqs6O/hQYopTqlEOCqdkPCwQbEAU/wxxAmMKxhI08IHekChaijqiap12LMflt&amp;TOPIC_ID=113643\" target=\"_blank\" class=\"external\">NHMRC: Practice guidelines on alcohol and other drug withdrawal, 2nd edition</a> (2012)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 113643 Version 1.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H2106922554\" id=\"outline-link-H2106922554\">International</a></li><li><a href=\"#H1073481588\" id=\"outline-link-H1073481588\">United States</a></li><li><a href=\"#H3291839487\" id=\"outline-link-H3291839487\">United Kingdom</a></li><li><a href=\"#H1927914767\" id=\"outline-link-H1927914767\">Australia</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-alcohol-use-disorders-and-withdrawal\" class=\"medical medical_society_guidelines\">Society guideline links: Alcohol use disorders and withdrawal</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-benzodiazepine-use-disorder-and-withdrawal\" class=\"medical medical_society_guidelines\">Society guideline links: Benzodiazepine use disorder and withdrawal</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-cannabis-use-disorder-and-withdrawal\" class=\"medical medical_society_guidelines\">Society guideline links: Cannabis use disorder and withdrawal</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-stimulant-use-disorder-and-withdrawal\" class=\"medical medical_society_guidelines\">Society guideline links: Stimulant use disorder and withdrawal</a></li></ul></div></div>","javascript":null}